Paper Details

  1. Home
  2. Paper Details

Possible prevention of chronic hepatitis B by early interferon therapy.

Author: CheminI, ChevallierP, ChossegrosP, PetitM A, SepetjanM, TrépoC, ZoulimF

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

A study of 15 patients with prolonged hepatitis B infection investigated the effectiveness of interferon therapy. Of the 6 patients who received interferon, 5 completely cleared the infection during treatment, with a rise in liver enzymes and temporary worsening of hepatitis. Two patients in the placebo group also cleared the infection. These results suggest that interferon treatment may prevent prolonged hepatitis B from becoming chronic. Further research is needed to confirm these findings and encourage more proactive screening for hepatitis B.
Paper Details　
Original Abstract of the Article :
A study is currently underway to investigate the efficacy of interferon therapy in patients with prolonged (greater than or equal to 10 weeks but less than 6 months) hepatitis B infection. To date, a total of 15 patients have been enrolled in the study and randomly assigned to receive either placebo...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/0168-8278(90)90172-n

データ提供：米国国立医学図書館（NLM）

Interferon Therapy: A Potential Game Changer for Hepatitis B

Hepatitis B, a viral infection that can lead to chronic liver disease, poses a significant health challenge worldwide. This research investigates the potential of interferon therapy in preventing the progression of hepatitis B to chronicity. The authors conducted a clinical trial involving patients with prolonged hepatitis B infection, comparing the effects of interferon therapy to placebo.

Hope in the Desert of Hepatitis B

The study's results suggest that interferon treatment can effectively eradicate hepatitis B infection in some patients, with complete clearance of viral markers and seroconversion to antibody positivity. This research is like finding a precious wellspring of hope in the desert of hepatitis B, offering a potential solution to a prevalent and serious health problem.

Early Detection and Intervention: Key to Preventing Chronicity

The study highlights the importance of early detection and intervention in managing hepatitis B infection. The authors suggest that vigilant screening for patients with elevated serum transaminase levels and viral markers of hepatitis B infection is crucial for preventing the progression to chronicity. This is like strategically scouting for oases in a vast desert, ensuring that appropriate interventions are deployed at the right time.

Dr. Camel's Conclusion

This study offers promising evidence that interferon therapy can effectively prevent the progression of hepatitis B to chronicity in some patients. The authors highlight the importance of early detection and intervention, emphasizing the need for vigilant screening and timely treatment. This research, like a guiding star illuminating the desert night, points towards a brighter future for patients with hepatitis B, offering hope for a successful resolution of this challenging disease.

Date :
  1. Date Completed 1991-04-30
  2. Date Revised 2019-08-17
Further Info :

Pubmed ID

1706741

DOI: Digital Object Identifier

10.1016/0168-8278(90)90172-n

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.